Research Article

Anopheles gambiae APL1 Is a Family of Variable LRR Proteins Required for Rel1-Mediated Protection from the Malaria Parasite, Plasmodium berghei

  • Michelle M. Riehle equal contributor,

    equal contributor Contributed equally to this work with: Michelle M. Riehle, Jiannong Xu

    Affiliation: Department of Microbiology, University of Minnesota, Saint Paul, Minnesota, United States of America

  • Jiannong Xu equal contributor,

    equal contributor Contributed equally to this work with: Michelle M. Riehle, Jiannong Xu

    Affiliation: Department of Microbiology, University of Minnesota, Saint Paul, Minnesota, United States of America

    Current address: Department of Biology, New Mexico State University, Las Cruces, New Mexico, United States of America

  • Brian P. Lazzaro,

    Affiliation: Department of Entomology, Cornell University, Ithaca, New York, United States of America

  • Susan M. Rottschaefer,

    Affiliation: Department of Entomology, Cornell University, Ithaca, New York, United States of America

  • Boubacar Coulibaly,

    Affiliation: Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Madjou Sacko,

    Affiliation: Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Oumou Niare,

    Affiliation: Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Isabelle Morlais,

    Affiliation: Laboratoire de Recherche sur le Paludisme, Institut de recherche pour le développement IRD-OCEAC, Yaoundé, Cameroun

  • Sekou F. Traore,

    Affiliation: Malaria Research and Training Center, University of Bamako, Bamako, Mali

  • Kenneth D. Vernick mail

    Affiliations: Department of Microbiology, University of Minnesota, Saint Paul, Minnesota, United States of America, Unit of Insect Vector Genetics and Genomics, Department of Parasitology and Mycology, CNRS Unit URA3012: Hosts, Vectors and Infectious Agents, Institut Pasteur, Paris, France

  • Published: November 07, 2008
  • DOI: 10.1371/journal.pone.0003672



We previously identified by genetic mapping an Anopheles gambiae chromosome region with strong influence over the outcome of malaria parasite infection in nature. Candidate gene studies in the genetic interval, including functional tests using the rodent malaria parasite Plasmodium berghei, identified a novel leucine-rich repeat gene, APL1, with functional activity against P. berghei.

Principal Findings

Manual reannotation now reveals APL1 to be a family of at least 3 independently transcribed genes, APL1A, APL1B, and APL1C. Functional dissection indicates that among the three known APL1 family members, APL1C alone is responsible for host defense against P. berghei. APL1C functions within the Rel1-Cactus immune signaling pathway, which regulates APL1C transcript and protein abundance. Gene silencing of APL1C completely abolishes Rel1-mediated host protection against P. berghei, and thus the presence of APL1C is required for this protection. Further highlighting the influence of this chromosome region, allelic haplotypes at the APL1 locus are genetically associated with and have high explanatory power for the success or failure of P. berghei parasite infection.


APL1C functions as a required transducer of Rel1-dependent immune signal(s) to efficiently protect mosquitoes from P. berghei infection, and allelic genetic haplotypes of the APL1 locus display distinct levels of susceptibility and resistance to P. berghei.


Malaria is a global health problem resulting in over 1 million deaths annually, with disproportionate mortality in African children under the age of five [1]. Malaria also imposes a large economic burden on developing countries. Current efforts to control this disease are multifaceted and include use of insecticides and insect barriers, drug therapy, and strengthening healthcare and research infrastructures [2]. More consistent and widespread implementation of existing tools would be beneficial, although technical problems such as selection for chemico-resistance in vectors and parasites emphasize the need for a new generation of malaria control tools [3].

One such new approach could be limiting the genetic propensity of vector mosquitoes to serve as competent hosts for parasite development, thus decreasing or abolishing their ability to transmit the causative agent. This approach is in its infancy and much remains to be done before we can evaluate specific genetic resistance mechanisms and the feasibility of manipulating them in nature.

We designed a phenotype-based method to genetically screen the wild A. gambiae population for genomic regions important in defense against P. falciparum [4]. Using this approach, we identified a genetic locus on chromosome 2L that consistently explains >80% of the variation in infection outcome (i.e., surviving oocyst numbers) in mosquitoes exposed to an infective bloodmeal, and thus captures most of the natural genetic variation for P. falciparum resistance or susceptibility [5]. The genetic interval, currently ~10 Mb, was termed the Plasmodium-Resistance Island (PRI). We then employed the rodent malaria laboratory model of P. berghei [6][12] to functionally screen candidate genes in the PRI. This work identified APL1, a novel leucine-rich repeat (LRR) containing protein [5]. When APL1 transcript abundance was reduced by RNAi gene knockdowns, the number of P. berghei oocysts was increased up to 20-fold, showing it to be a potent factor for host defense against P. berghei infection [5].

Here, we reannotate the original APL1 gene as a gene family of 3 related members, APL1A, B, and C. Gene-specific RNAi assays show that all of the malaria-protective activity we previously reported for A. gambiae APL1 can now be attributed exclusively to APL1C. We functionally dissect the position of APL1C in mosquito immune signaling networks, placing APL1C as a required node in Rel1-mediated host defense against P. berghei infection. Finally, we identify haplotypes in the APL1 locus that are genetically associated with the degree of phenotypic susceptibility to P. berghei infection.


Reannotation of the ENSEMBL prediction for APL1

Examination of APL1 at the time of our original description [5] suggested that its annotation as a single gene (ENSANGG00000012041 in ENSEMBL version 44 and earlier) was incorrect. The previous ENSEMBL prediction for APL1 lacked start and stop codons, predicting a partial protein consisting of little more than a string of LRR domains. Resequencing of genomic DNA and archived clones from the original A. gambiae sequencing project [13], as well as transcript mapping, revealed that the previous APL1 gene represented the erroneous annotation of a gene family comprised of at least 3 tandem LRR-containing genes, here named APL1A, APL1B, and APL1C (Figure 1A). Each of the 3 genes has a short 5′ exon followed by a small intron and a longer second exon, and each has a block of LRR motifs flanked by an N-terminal signal peptide and C-terminal coiled coil domains (Figure 1B). The three individual APL1 genes display sequence similarity that likely results from gene duplication and functional diversification (diagonals in Figure S1), and we therefore class them together as the APL1 family.


Figure 1.

A. Reannotation of the APL1 region. i) Ensembl release version 36, ii) Ensembl release version 41, iii) Ensembl release version 45, iv) Empirical annotation of APL1A, B and C in this article and Vectorbase manual annotation database, v) Fragments used for RNA interference assays; common dsRNA fragment knocking down APL1A, B and C (pink), unique dsRNA fragments at the 3′ end of each gene used for gene-specific knockdowns (yellow), vi) 5′ and 3′ RACE fragments used to delimit transcripts. B. APL1 family protein functional motifs. Predicted peptide domains are indicated as follows: red, signal peptide; green, coiled-coil domain; light blue vertical bars, leucine rich repeats; blue, regions of intrinsic disorder, pink, segments of low complexity; and purple, repeat regions. Haplotypic versions of the APL1 proteins as discussed in the text differ in functional predictions, with PEST strain predictions being most similar to the APL1A2, B2, and C2 haplotypic forms.


There were notable structural differences between the resequencing results and the ENSEMBL genome assembly (discussed in order below): i) the presence of structurally polymorphic haplotypes, and ii) a polymorphic and/or active transposable element. First, all three APL1 family genes display major structural haplotypes (Figure 1B). The differences between allelic forms are most striking for APL1A and APL1C. Variants can differ in the locations of their predicted stop codons, resulting in predicted proteins of distinct lengths, and also by the presence of multiple polymorphic insertion-deletion (indel) sites within the protein coding sequence (CDS). The indels are precisely in-frame with the surrounding protein. Thus, the indels do not introduce missense mutations but rather encode small peptide cassettes that are present or absent, respectively, in the predicted finished protein. In a sample of wild and colony mosquitoes, indel alleles appear consistently linked to specific surrounding nucleotide variants (discussed below), thus establishing the indels as reliable markers for stable haplotypes that encode predicted proteins of distinct sizes and structure. The haplotypes are designated by the gene name followed by a superscript number (Figure 1B). The superscript 2 haplotype for each gene is most similar to the variant found in the PEST strain used for the A. gambiae genome sequence.

Another structural difference revealed by resequencing occurs upstream of the APL1A gene, where we found that a tract of Ns in the public genome assembly is actually (in PEST strain plasmid clone 19600445759751) a TA-III-Ag miniature inverted transposable element (MITE, [14]). The ambiguous bases in the ENSEMBL genome sequence may result from the difficulty in sequencing the repetitive region, or perhaps from the polymorphic state of the MITE in the sequence template. The G3 strain lacks the MITE in this genomic location.

APL1C is required for the control of P. berghei infection

We previously demonstrated that the APL1 family had a pronounced effect on P. berghei oocyst intensity in an RNAi gene expression knockdown assay [5]. In that case, the double-stranded RNA (dsRNA) fragment injected into mosquitoes was fortuitously common to a portion of all three APL1 family genes (Figure 1A, track v, homology regions of APL1-common dsRNA indicated by pink bars; also Figure S1B), because at the time APL1 was annotated as a single gene. Based on our current reannotation of APL1, we wondered whether the source of our previously reported APL1 knockdown phenotype was a single APL1 family member, or alternatively a combined effect of all 3 members. To test this, we conducted knockdown experiments using new dsRNA constructs specific for each of the APL1 family members (locations of dsRNAs shown in Figure 1A, track v, yellow bars). The results indicate that among the APL1 family, APL1C alone is responsible for the control of P. berghei oocyst intensity (Figure 2). Oocyst loads in either APL1A or APL1B knockdown mosquitoes were statistically indistinguishable from those of the GFP controls, while APL1C knockdown mosquitoes carried oocysts loads ~20 times greater than GFP controls (p<0.05). The effect of the APL1-common dsRNA fragment that silences the three genes was not different from the APL1C specific dsRNA, indicating that the effect of APL1C is both necessary and sufficient to explain APL1 protective function against infection with P. berghei.


Figure 2. Among the APL1 family, only APL1C specifically protects against P. berghei infection.

The three APL1 family genes were individually assayed to determine their relative contributions to host defense against P. berghei infection. Horizontal axis indicates the gene target of RNAi knockdown, where APL1A, B and C are gene-specific knockdowns, GFP is an irrelevant control dsRNA, and APL1 is a shared dsRNA that simultaneously knocks down all 3 APL1 family genes. Vertical axis indicates the number of midgut oocysts 7–8 d following IBM, with sample size (n), mean (mean), and median (med). Infection levels in APL1A and APL1B silenced mosquitoes were not different from GFP controls. However, treatment with either dsAPL1C or dsAPL1 (targeting all 3 genes) permitted significantly greater oocyst development than the other treatments (asterisk, p<0.05 by Dunn's Multiple Comparison after Kruskal Wallis one way ANOVA on ranks). Infections of APL1C and APL1 silenced mosquitoes were not different from each other, indicating that the function of APL1C alone is sufficient to explain all of the increased permissiveness caused by complete APL1 family knockdown. The result for each knockdown target represents pooled data from at least 2 independent replicate experiments. One of the common APL1 knockdowns was done alongside an APL1C kd, and when assayed in the same replicate, there was no significant difference between APL1C kd and common APL1 kd (p = 0.481). The inset gel photo shows representative examples of gene knockdown efficiency for the 3 members of the APL1 gene family. Labels above gel images indicate the dsRNA that was used for the knockdown. Labels to the left of images indicate the transcript detected by RT-PCR on RNA purified from the treated mosquitoes. rps7 was used as a control for cDNA input in PCR.


APL1C activity is required for anti-P. berghei protection mediated by the Toll/Rel1 pathway

The Toll signaling pathway controls cellular and humoral innate immune signaling, including activation of anti-fungal and anti-Gram positive bacteria defense in Drosophila [15], [16] The genes for the core components of the pathway are also found in the A. gambiae and Aedes aegypti genomes [17], [18]. Mosquito Rel1, ortholog of Drosophila Dorsal and functional analog of Drosophila Dif, is an ultimate transcription factor of the Toll pathway [11], [19], [20]. Under naïve conditions, Rel1 is retained in the cytoplasm due to binding of the inhibitor, Cactus. Activation of the Toll receptor by its ligand spatzle in response to pathogens results in the disassociation of Cactus from Rel1 [21]. Released Rel1 translocates to the nucleus where it transactivates target genes. Recently, Frolet et al. [11] have shown that Rel1 regulates the transcription of TEP1 and LRIM1, two anti-Plasmodium genes in A. gambiae, and that depletion of the Rel1 inhibitor, Cactus, by RNAi strongly promoted mosquito host defense against P. berghei. In the same study, it was claimed that APL1 was not transcriptionally regulated by Rel1. However, the PCR assay used for the APL1 expression in their study was actually specific for the AGAP007037 gene (upstream of APL1A), which was incorrectly annotated as an exon of APL1.

A specific assay for the expression of APL1C, the only anti-P. berghei gene among the 3 APL1 genes, reveals that APL1C is in fact regulated by Rel1, as determined by its expression in Rel1 and Cactus knockdown mosquitoes (Figure 3). APL1C transcription was reduced in dsRel1 treated mosquitoes, and increased in dsCactus treated mosquitoes (Figure 3A). Furthermore, APL1C protein abundance was elevated following P. berghei infection, and this elevation was enhanced by dsCactus (Figure 3B). Boosting Rel1 signaling by depletion of Cactus enables mosquitoes to eliminate almost all invaded malaria parasites within 48 h post-infection [11]. If APL1C is a host-protective gene regulated by Rel1/Cactus signaling, then the anti-P. berghei effect of dsCactus should be reduced in the absence of APL1C expression. To test this hypothesis, we examined the effect of a dsCactus/dsAPL1C double knockdown on the outcome of P. berghei infection. As expected, control mosquitoes treated only with dsCactus eliminated all invaded parasites by either lysis or melanization responses. Most dsCactus mosquitoes (24/36) harbored no parasites on day 7 post-IBM, while the remaining third of the mosquitoes (12/36) displayed melanized parasites (range 1–19 melanized parasites/mosquito) but no normal oocysts. Interestingly, this elevated parasite resistance of dsCactus treated mosquitoes was completely reversed when APL1C was silenced simultaneously with Cactus, because the oocyst load in mosquitoes treated with dsCactus/dsAPL1C was equivalent to that in dsAPL1C/dsGFP treated mosquitoes (Figure 3C). These results indicate that APL1C is a required mediator of the anti-P. berghei effect controlled by Rel1 signaling, because constitutive activation of Rel1 signaling by Cactus depletion, which is normally entirely protective for mosquitoes, had no effect in the absence of APL1C. Treatment of mosquitoes with dsRNA for two other mosquito immune factors, TEP1 and LRIM1, only partially reversed the dsCactus phenotype in double knockdowns, allowing development of some normal P. berghei parasites [11]. However, because Cactus depletion confers no host-protective phenotype without the presence of APL1C, it appears that the effect of APL1C is functionally dominant in this anti-P. berghei pathway. We hypothesize that APL1C may be a functionally upstream signaling node responsible for the coordinated Rel1-dependent control of multiple host protective factors.


Figure 3.

A. APL1C mRNA is regulated by the Rel1/Cactus immune signaling pathway. Semi-quantitative RT-PCR was used to measure the effect of Rel1 and Cactus knockdown on APL1C transcript abundance. Labels above gel indicate the dsRNA that was used for the knockdown, labels to the left indicate the transcript whose abundance was measured. APL1C level was decreased by Rel1 silencing, and increased by Cactus silencing, consistent with a model whereby APL1C RNA is regulated positively by Rel1 and negatively by Cactus. Specificity is shown by dsRel1 and dsCactus silencing of cognate RNA levels. B. APL1C protein abundance is regulated by P. berghei infection and Cactus. Western blot analysis of APL1C protein abundance 24 h after P. berghei infection in naïve, dsCactus knockdown, and dsGFP control mosquitoes. Total protein abundance of ERK detected by anti-ERK antibodies was used as a protein loading control. C. APL1C is required for Rel1-mediated host-defense against P. berghei. The functional effect of Cactus and APL1C activity on the outcome of P. berghei infection was tested using gene knockdowns. The RNAi knockdown target is shown on the horizontal axis. GFP was used as a control dsRNA. The vertical axis shows the number of midgut oocysts 7–8 d following a P. berghei IBM. Sample sizes (n), means (mean), and medians (med) are given for knockdowns, which were each pooled data from 2 independent experiments. The oocyst loads differed significantly (p<0.001) among samples by Kruskal Wallis one way ANOVA on Ranks. Pairwise comparisons using Dunn's method of multiple comparisons are given in the inset box. dsCactus-treated mosquitoes were completely protected from infection, with no successful oocyst development. In distinction, the double knockdown of APL1C simultaneously with Cactus produced mosquitoes with ~25-fold more oocysts than the dsGFP-treated controls, a result that was no different than the dsAPL1C-treated mosquitoes. Thus, in the absence of APL1C, Rel1 activation has no effect on parasite development, indicating the requirement of the presence of APL1C for Rel1-mediated host defense against P. berghei. Note that dsGFP was included in the APL1C knockdown so that total amount of input dsRNA per mosquito was the same as in the Cactus-APL1C double knockdown, eliminating dsRNA concentration as a variable.


Haplotypes at the APL1 locus are genetically associated with protection from P. berghei infection

Resequencing and reannotation of the APL1 locus identified major structural haplotypes that include alleles of APL1A, APL1B, and APL1C (Figure 1B). We hypothesized that the genetic and predicted protein variation in this locus could control differences for host defense against P. berghei. If true, one could test for the phenotypic effect of different haplotypes by detecting association of haplotype-specific markers with phenotypic outcome after P. berghei infection.

To design a genetic assay for haplotype, we resequenced part of the APL1A and APL1C genes in a sample of colony and wild mosquitoes. Patterns of specific SNPs distinguish the APL1 haplotypes and are stable among mosquitoes of distinct geographic origins (Figure 4A). Thus, we designed a simple PCR fragment length assay to detect the genotype of indels in APL1A (Figure 4B, C). Typing of multiple mosquitoes using the PCR assay indicated that the indels are linked to and diagnostic for the APL1 haplotypes (not shown). In summary, the APL1A1 haplotype bears the deleted variant of an indel located in exon 2, while APL1A2 bears the inserted variant for this indel. APL1A2 bears the deleted variant of an indel located 5′ to the predicted translation start site, while APL1A1 bears the inserted variant of this indel (Figure 4B). The exon 2 indel is an in-frame CDS deletion, which consequently alters the length of the predicted protein product but does not introduce missense/nonsense mutations (not shown).


Figure 4.

A. APL1 alleles are comprised of blocks of linked SNPs. Nucleotide alignment shows APL1A and APL1C genetic variation in a sample of A. gambiae wild and colony mosquitoes. Haplotypes are shared over the resequenced region between individual mosquitoes, indicating that the variants are stable haplotypes that exist in A. gambiae at appreciable frequency. B. Genotyping assay for segregating indels in the APL1 locus. A PCR assay was designed to test the state of 2 indels in APL1A that are markers for allelic haplotypes at the APL1 locus. Arrows show forward and reverse primers used in the diagnostic assay, dashed lines indicate indels (located within exon 2 of APL1A1, and above the translation start in APL1A2), asterisk indicates the start codon of APL1A. C. Indel genotyping assay. A representative gel of PCR products from the indel diagnostic assay, lane 1, Lambda HindIII/PhiX HaeIII marker, lane 2, APL1A2 homozygote (854 bp), lane 3, a heterozygote with codominant bands, lane 4, APL1A1 homozygote (663 bp). D. APL1 locus haplotypes control distinct levels of protection from P. berghei infection. Homozygous APL1A2 mosquitoes were significantly less permissive for parasite development than APL1A1/APL1A2 heterozygotes (asterisk, p<0.001, Mann Whitney Rank Sum Test; sample size (n), mean (mean), and median (med) given for each haplotype). Homozygous APL1A1 individuals are present at low frequency in the sampled colony and thus were not included in the analysis (see Results for further details on APL1A1 haplotype frequency).


We challenged the G3 strain A. gambiae with a P. berghei-infected bloodmeal, and used the indel genotyping assay to query for an association between APL1 genotype and infection outcome (Figure 4D). Mosquitoes that were homozygous for APL1A2 had significantly lower oocyst loads (average = 5.3±2.5) than APL1A1/APL1A2 heterozygotes (average = 31.7±6; Mann Whitney Rank Sum Test, p<0.001). Furthermore, the prevalence of infection in homozygous APL1A2 mosquitoes was lower (37.5%; 9/24) than that in APL1A1/APL1A2 heterozygotes (84.5%; 41/48; Fisher's Exact Test, p<0.001).

Thus, the haplotype-tagging indels are linked to genetic variation that controls significant difference in numbers of surviving P. berghei oocysts. We emphasize that the indels serve as genetic markers to detect the phenotypic effect of linked variant sequences, and linkage does not imply that the marker itself underlies the observed phenotypic variation. Like any other genetic marker in common use, for example almost all microsatellites and SNPs in any given genome, the allelic variation of the marker itself is presumed to be neutral for the trait under examination. Thus, further genetic studies will be necessary to resolve the underlying cause at the APL1 locus of this phenotypic difference.

Based on the observation that APL1A2 homozygotes are less susceptible and APL1A1/APL1A2 heterozygotes are more susceptible to P. berghei infection, one might predict that APL1A1 homozygotes would in turn be exceedingly susceptible for infection. However, the G3 colony of A. gambiae displays a low frequency of APL1A1 homozygotes (8%) and thus the sample sizes of these individuals (n = 2) obtained after a moderate number of infections was too small to include in the statistical analyses. The APL1A1 homozygotes must certainly be generated each generation by the mating of heterozygotes, but due to their low frequency their fate and potential infection phenotype remains an open question. Typing mosquito developmental stages using the haplotype diagnostic showed the same haplotype frequencies in eggs and larvae as in adults (data not shown), suggesting that loss of the APL1A1 homozygotes is not developmental but rather prezygotic.


We demonstrate by RNAi gene silencing experiments that APL1C activity is necessary to provide a high level of host-protective activity against P. berghei infection. By genetic association, we show that variant haplotypes at the APL1 locus confer distinct levels of parasite susceptibility or resistance. Further functional and cell biological studies will be necessary to understand the role of APL1C in host defense against P. berghei and other parasite species, most importantly the human malaria parasite, P. falciparum. Further genetic studies will be required to dissect the functional basis of the distinct infection phenotypes linked to the APL1 haplotypes.


Sequence Generation and Comparison

For PCR amplification and subsequent sequencing of the APL1 region, DNA was isolated from a single female G3 strain mosquito using Qiagen DNeasy (Qiagen, CA, USA). Diploid sequence was obtained via standard Sanger sequencing at the BioMedical Genomics Center at the University of Minnesota and assembled using Seqman (DnaStar, WI, USA). Due to the diploid nature of the starting DNA, no phase information is known and ambiguous base calls are given for reliably called heterozygous positions.

Three PEST clones (Clones 19600445682690, 19600445759751, 19600445654898) spanning this APL1 region were obtained from the Malaria Research and Reference Reagent Resource Center, MR4 ( Clones overlapping the APL1 gene predictions were sequenced and assembled as described above (map in Figure S1C). The three assembled sequences (G3, ENSEMBL, and PEST clones) were aligned and a comparison plot drawn using ACT [22]. The score cut-off was set to 100, the % ID cutoff to 50% and the minimum size of matches was set to 100 bp or greater.

Manual Annotation of the APL1 Gene Family

Both molecular biology and in silico approaches were used to manually annotate the three member genes of the APL1 family. All wet biology work was done on cDNA synthesized from total RNA isolated from a pool of 30 G3 strain female mosquitoes. Gene model predictions from a whole genome in silico prediction of the A. gambiae genome [23] were considered alongside data from 5′ and 3′ RACE reactions (First Choice RLM-RACE Kit, Ambion, Ca, USA) run with gene specific primers for APL1A and APL1C including apl1A_5′_end_R GATGGCTGTCCTCCGTTGGTACAGGC, apl1C_5′_end_R CCGTAATTTGGCTGACTTCTGTAGATT, apl1A_3′_end_F CAGCAGCAGCTCCTAGCAAGACTGCA, and apl1C_3′_end_F GGCAAGCGTTTAAGTTGCGCGAAACGCA and 5′ forward and 3′ reverse adaptor primers. The APL1B transcript was determined by designing primers to include all possible upstream start and downstream stop codons and screening for PCR amplification. Once the extent of transcripts was determined using this combinatorial approach, complete sequences were amplified by PCR and Sanger sequenced resulting in complete sequence of the coding regions and the ability to predict the underlying polypeptide. The resulting new gene models were submitted to Vectorbase ( as manual annotation entries (data deposition APL1, manual). Three independently transcribed genes with start and stop codons are now included beginning with ENSEMBL release version 45: AGAP007036, APL1A; AGAP007035, APL1B; and AGAP007033, APL1C.

Protein Structural Architecture of the APL1 Family

Predicted peptide sequences of the haplotypic forms of the APL1 family were generated from the resequencing data described above and were aligned using ClustalX [24]. SMART [25] was used to obtain predictions for the protein domains using HMMER searches and also searching for outlier homologues, Pfam domains, signal peptides, internal repeats, and regions of intrinsic protein disorder. The protein domains depicted in Figure 1B are adapted from SMART output that only displays domains more significant than established cutoffs. When two or more features occupy the same region, the following order of preference was used SMART>PFAM>PROSPERO repeats>Signal peptide>Transmembrane>Coiled coil>Unstructured regions>Low complexity.

APL1C Antibodies

An APL1C specific gene fragment was PCR amplified with the following primers APL1C_F 5′ CAAGCGTTTAAGTTGCGCGAAACGCAG and APL1C_R 5′ CTACTTTGTAACGCGACGCGTATCTGG. The fragment was expressed from the pet-46 Ek/LIC vector (Novagen, CA, USA), and was used for production of rabbit antisera. IgG was purified from serum using Protein A IgG Purification Kit from Pierce Biotechnology (Rockford, IL, USA), and made to a concentration of 1 mg/ml. Mosquito proteins were separated by 4–12% SDS-PAGE gels of the NuPAGE Novex Bis-Tris system (Invitrogen, Carlsbad, California, USA), transferred to the Nitrocellulose membrane. Immunoblotting with the antibody against APL1C (1:1000 dilution) was done with the Protein Detector LumiGLO Western Blotting kit (KPL, Gaithersburg, Maryland, USA). The protein loads on the blot were checked by staining with anti-ERK2 total antibody (item K-23 #sc-153, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a concentration suggested by the supplier.

RNA Interference Assays

Gene specific fragments of APL1 A, B and C, Rel, Cactus and GFP were produced by PCR using oligos tagged at 5′end with T7 promoter sequence. The primers used were: GFP_F 5′ AGTGGAGAGGGTGAAGGTGA, GFP_R 5′ CACGTGTCTTGTAGTTCCCG, APL1A_F 5′ CTACCACCTGCCGAAAGATG, APL1A_R 5′ TCTGGTCTTGTATAGTACAATGG, APL1B_F 5′ TGAGAACAAATAAGTTCAAAGTCC, APL1B_R 5′ ACTCGCAAAGCTCAGCAAACAC, APL1C_F 5′ CCAAGAAGAACCGCAATCC and APL1C_R 5′ TCACAGTGATTTCAGGGTGTGC, REL1_F 5′GGCCCTAGTCAGCCGCAGCCG and REL1_R 5′GGGGGGTTGGAATGGATGCTT ; CACTUS_F 5′ GGTGGTGCGTCGATTGCTGG and CACTUS_R 5′ GGCTTTCGTTCAAGTTCTGTGC (all primers contained a T7 promoter sequence, 5′ TAATACGACTCACTATAGG for use in synthesizing dsRNA; the GFP fragment was used as a dsRNA control). The PCR products were used as templates for dsRNA synthesis using the MEGAscript T7 Kit (Ambion, TX, USA). Four d after the dsRNA treatment, knockdown of the target gene was verified. dsRNA treated mosquitoes were fed on mice infected with PbGFPCON (8–12% parasitaemia with mature gametocytes), a transformed strain of P. berghei constitutively expressing GFP [26] at 8–12% parasitaemia with mature gametocytes. Seven to 8 d following infective blood meal, midgut oocysts were counted using a florescence microscope. To compare oocyst numbers across treatments non-parametric statistical tests were used, including the Mann Whitney Rank Sum Test and the Kruskal Wallis ANOVA on ranks. For each RNAi experiment at least 30 mosquitoes survived and were counted for oocyst load. Two to 4 independent replicate infections were performed and data was pooled prior to statistical analysis.

Indel Genotype-Phenotype Association Study

During the sequencing of the APL1 gene family in a single G3 colony mosquito 2 segregating variants (haplotypes) were discovered (see Results). Based on available DNA sequence from homozygotes of the two segregating haplotypes, a PCR based diagnostic assay was designed to detect 2 segregating indels within APL1A. The first indel (46 bp in length) was located 109 bp upstream of the predicted translation start site and the second indel (237 bp in length) was located in the second exon. Amplification across this variable region results in differences in PCR product length of 191 bp in the APL1A gene, and was used to genotype mosquitoes for allelic haplotypes of the APL1 locus. Homozygous APL1A1 individuals displayed a single PCR of 663 bp, homozygous APL1A2 individuals displayed a single PCR band of 854 bp, and heterozygotes displayed both bands. The primers used in the haplotype diagnostic assay were 5′ GCT GGA TCC CAA CTA GTG CTG TT and 5′ AGT AAA GCA GCG GGC AGT TTG C. PCR conditions were 94°C for 1 minute, followed by 30 cycles of 94°C for 30 sec, 58°C for 30 sec, and 72°C for 45 sec and a final extension of 72°C for 7 minutes. To query for an association between haplotype and infection phenotype, G3 mosquitoes were fed on mice infected with the PbGFPCON strain of P. berghei (18) as described above. Seven to eight days post blood feeding midguts were dissected, oocysts counted, mosquito genomic DNA extracted from carcasses, and APL1A haplotype was determined by the diagnostic assay for each individual. Three replicate infections were performed and data was analyzed with a non-parametric Wilcoxon Mann Whitney test.

Supporting Information

Figure S1.

A. Reannotation of the APL1 region (reproduced from main text for clarity with Figure S1). i) Ensembl release version 36, ii) Ensembl release version 41, iii) Ensembl release version 45, iv) Empirical annotation of APL1A, B and C in this article and Vectorbase manual annotation database, v) Fragments used for RNA interference assays; common dsRNA fragment knocking down APL1A, B and C (pink), unique dsRNA fragments at the 3′ end of each gene used for gene-specific knockdowns (yellow), vi) 5′ and 3′ RACE fragments used to delimit transcripts. B. Genomic similarity. ACT Sequence Comparison plot of i) a single G3 female, ii) the genomic sequence of A. gambiae from ENSEMBL and iii) sequence from three PEST clones spanning the region. Score cut-off was set at a minimum of 100, per cent ID cut-off was set to a minimum 50% and minimum size of matches was set to 100 bp or greater. Greater sequence identity is indicated by darker shade of red. Extensive sequence similarity is evident across the APL1 locus region, with many regions >95% and most >90%. The assembled PEST strain sequence at ENSEMBL shows greater similarity to independent PEST clones than it does to G3. The LRR regions of the APL1 genes show greatest intergene similarity (diagonals). The largest region of sequence dissimilarity occurs upstream of the 5′ end of the APL1A gene. Here the ENSEMBL sequence is a string of Ns (see white box in track ii), the PEST clone has a miniature inverted transposable element (MITE) of the TA-III-Ag family based on terminal inverted repeat sequence and the G3 sequence has no MITE. C. Overlap of the PEST strain clones with the APL1 gene family. a) The APL1 gene family as presented throughout this paper, APL1A (green), APL1B (red), and ALP1C (blue) (b) The three PEST clones obtained from MR4.


(1.62 MB TIF)

Author Contributions

Conceived and designed the experiments: MMR JX SFT KV. Performed the experiments: MMR JX BPL SMR BC MS ON IM. Analyzed the data: MMR JX KV. Contributed reagents/materials/analysis tools: MMR JX BPL. Wrote the paper: MMR JX KV.


  1. 1. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW (2004) The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 4: 327–336.
  2. 2. Breman JG, Alilio MS, Mills A (2004) Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg 71: 1–15.
  3. 3. Vernick KD, Waters AP (2004) Genomics and malaria control. N Engl J Med 351: 1901–1904.
  4. 4. Niare O, Markianos K, Volz J, Oduol F, Toure A, et al. (2002) Genetic loci affecting resistance to human malaria parasites in a west african mosquito vector population. Science 298: 213–216.
  5. 5. Riehle MM, Markianos K, Niare O, Xu J, Li J, et al. (2006) Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science 312: 577–579.
  6. 6. Osta MA, Christophides GK, Kafatos FC (2004) Effects of mosquito genes on Plasmodium development. Science 303: 2030–2032.
  7. 7. Volz J, Muller HM, Zdanowicz A, Kafatos FC, Osta MA (2006) A genetic module regulates the melanization response of Anopheles to Plasmodium. Cell Microbiol 8: 1392–1405.
  8. 8. Volz J, Osta MA, Kafatos FC, Muller HM (2005) The roles of two clip domain serine proteases in innate immune responses of the malaria vector Anopheles gambiae. J Biol Chem 280: 40161–40168.
  9. 9. Abraham EG, Pinto SB, Ghosh A, Vanlandingham DL, Budd A, et al. (2005) An immune-responsive serpin, SRPN6, mediates mosquito defense against malaria parasites. Proc Natl Acad Sci U S A 102: 16327–16332.
  10. 10. Arrighi RB, Lycett G, Mahairaki V, Siden-Kiamos I, Louis C (2005) Laminin and the malaria parasite's journey through the mosquito midgut. J Exp Biol 208: 2497–2502.
  11. 11. Frolet C, Thoma M, Blandin S, Hoffmann JA, Levashina EA (2006) Boosting NF-kappaB-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei. Immunity 25: 677–685.
  12. 12. Michel K, Budd A, Pinto S, Gibson TJ, Kafatos FC (2005) Anopheles gambiae SRPN2 facilitates midgut invasion by the malaria parasite Plasmodium berghei. EMBO Rep 6: 891–897.
  13. 13. Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, et al. (2002) The genome sequence of the malaria mosquito Anopheles gambiae. Science 298: 129–149.
  14. 14. Tu Z (2001) Eight novel families of miniature inverted repeat transposable elements in the African malaria mosquito, Anopheles gambiae. PNAS 98: 1699–1704.
  15. 15. Lemaitre B, Hoffmann J (2007) The Host Defense of Drosophila melanogaster. Annu Rev Immunol 25: 697–743.
  16. 16. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973–983.
  17. 17. Christophides GK, Zdobnov E, Barillas-Mury C, Birney E, Blandin S, et al. (2002) Immunity-related genes and gene families in Anopheles gambiae. Science 298: 159–165.
  18. 18. Nene V, Wortman JR, Lawson D, Haas B, Kodira C, et al. (2007) Genome Sequence of Aedes aegypti, a Major Arbovirus Vector. Science.
  19. 19. Shin SW, Bian G, Raikhel AS (2006) A toll receptor and a cytokine, Toll5A and Spz1C, are involved in toll antifungal immune signaling in the mosquito Aedes aegypti. J Biol Chem 281: 39388–39395.
  20. 20. Bian G, Shin SW, Cheon HM, Kokoza V, Raikhel AS (2005) Transgenic alteration of Toll immune pathway in the female mosquito Aedes aegypti. Proc Natl Acad Sci U S A 102: 13568–13573.
  21. 21. Belvin MP, Jin Y, Anderson KV (1995) Cactus protein degradation mediates Drosophila dorsal-ventral signaling. Genes Dev 9: 783–793.
  22. 22. Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, et al. (2005) ACT: the Artemis comparison tool. Bioinformatics 21: 3422–3423.
  23. 23. Li J, Riehle MM, Zhang Y, Xu J, Oduol F, et al. (2006) Anopheles gambiae genome reannotation through synthesis of ab initio and comparative gene prediction algorithms. Genome Biol 7: R24.
  24. 24. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876–4882.
  25. 25. Letunic I, Copley RR, Pils B, Pinkert S, Schultz J, et al. (2006) SMART 5: domains in the context of genomes and networks. Nucleic Acids Res 34: D257–260.
  26. 26. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, et al. (2004) A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137: 23–33.